Skip to main content

olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide

NDC 49884-787 · Par Health USA, LLC

Generic nameolmesartan medoxomil / amlodipine besylate / hydrochlorothiazide
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)OLMESARTAN MEDOXOMIL, AMLODIPINE BESYLATE, HYDROCHLOROTHIAZIDE
Strength5; 12.5; 40 mg/1; mg/1; mg/1
Pharmacologic classAngiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
Marketing categoryANDA

Packages

49884-787-09 — 90 TABLET, FILM COATED in 1 BOTTLE (49884-787-09)

49884-787-11 — 30 TABLET, FILM COATED in 1 BOTTLE (49884-787-11)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

46708-764 — Amlodipine and Atorvastatin, 46708-765 — Amlodipine and Atorvastatin, 48433-090 — spironolactone and hydrochlorothiazide, 48433-155 — Amlodipine Besylate, 48433-156 — Amlodipine Besylate, 48433-157 — Amlodipine Besylate, 49252-065 — olmesartan medoxomil, 49252-066 — olmesartan medoxomil, 49252-067 — OLMESARTAN MEDOXOMIL, 49884-786 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 49884-788 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 49884-789 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 49884-790 — olmesartan medoxomil / amlodipine besylate / hydrochlorothiazide, 50090-0140 — Hydrochlorothiazide, 50090-0141 — Hydrochlorothiazide, 50090-0724 — hydrochlorothiazide, 50090-1042 — Amlodipine and Benazepril Hydrochloride, 50090-1088 — Hydrochlorothiazide, 50090-1270 — Triamterene and Hydrochlorothiazide, 50090-1418 — Amlodipine and Benazepril Hydrochloride, +1450 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels